Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in Hum Pathol

Retrieve available abstracts of 62 articles:
HTML format



Single Articles


    January 2021
  1. CHATZOPOULOS K, Kotoula V, Koliou GA, Giannoulatou E, et al
    Genotype-phenotype associations in colorectal adenocarcinomas and their matched metastases.
    Hum Pathol. 2021;107:104-116.
    PubMed     Abstract available


  2. GONZALEZ IA, Bauer PS, Liu J, Chatterjee D, et al
    Adenoma-like adenocarcinoma: clinicopathologic characterization of a newly recognized subtype of colorectal carcinoma.
    Hum Pathol. 2021;107:9-19.
    PubMed     Abstract available


    November 2020
  3. ESCOBAR D, Jones R, Gao J, Sun L, et al
    Unique clinicopathologic and genetic alteration features in early onset colorectal carcinoma compared with age-related colorectal carcinoma: a large cohort next generation sequence analysis.
    Hum Pathol. 2020;105:37-46.
    PubMed     Abstract available


    October 2020
  4. SAPPENFIELD R, Gonzalez IA, Cao D, Chatterjee D, et al
    Well-differentiated rectal neuroendocrine tumors: analysis of histology, including insulinoma-associated protein 1 expression, and biologic behavior, involving a large cohort of 94 cases.
    Hum Pathol. 2020;104:66-72.
    PubMed     Abstract available


    September 2020
  5. CHEN W, Hampel H, Pearlman R, Jones D, et al
    Unexpected expression of mismatch repair protein is more commonly seen with pathogenic missense than with other mutations in Lynch syndrome.
    Hum Pathol. 2020;103:34-41.
    PubMed     Abstract available


    May 2020
  6. GUI X, Iacucci M, Ghosh S, Ferraz JGP, et al
    Revisiting the Distinct Histomorphologic Features of Inflammatory Bowel Disease -Associated Neoplastic Precursor Lesions in SCENIC and Post-DALM Era.
    Hum Pathol. 2020 May 5. pii: S0046-8177(20)30083.
    PubMed     Abstract available


  7. VILLATORO TM, Ma C, Pai RK
    Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
    Hum Pathol. 2020;99:53-61.
    PubMed     Abstract available


    April 2020
  8. LIN MT, Zheng G, Tseng LH, Zhang P, et al
    Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
    Hum Pathol. 2020;98:120-128.
    PubMed     Abstract available


    January 2020
  9. MILLER GC, Liu C, Bettington ML, Leggett B, et al
    Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
    Hum Pathol. 2020 Jan 6. pii: S0046-8177(19)30234.
    PubMed     Abstract available


    November 2019
  10. CHEN W, Pearlman R, Hampel H, Pritchard CC, et al
    MSH6 Immunohistochemical heterogeneity in colorectal Cancer: comparative sequencing from different tumor areas.
    Hum Pathol. 2019 Nov 26. pii: S0046-8177(19)30216.
    PubMed     Abstract available


  11. HORI Y, Yamamoto H, Nozaki Y, Torisu T, et al
    Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
    Hum Pathol. 2019 Nov 14. pii: S0046-8177(19)30168.
    PubMed     Abstract available


    May 2019
  12. CECCHINI MJ, Walsh JC, Parfitt J, Chakrabarti S, et al
    CDX2 and Muc2 immunohistochemistry as prognostic markers in stage II Colon Cancer.
    Hum Pathol. 2019 May 20. pii: S0046-8177(19)30090.
    PubMed     Abstract available


  13. LANG-SCHWARZ C, Melcher B, Haumaier F, Schneider-Fuchs A, et al
    Budding, tumor infiltrating lymphocytes, gland formation: scoring leads to new prognostic groups in WHO-low grade colorectal cancer with impact on survival.
    Hum Pathol. 2019 May 2. pii: S0046-8177(19)30071.
    PubMed     Abstract available


  14. ALPERT L, Yassan L, Poon R, Kadri S, et al
    Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
    Hum Pathol. 2019 May 2. pii: S0046-8177(19)30078.
    PubMed     Abstract available


  15. PARK HY, Kwon MJ, Kang HS, Kim YJ, et al
    Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
    Hum Pathol. 2019;87:83-94.
    PubMed     Abstract available


  16. BASHIR B, Merlino DJ, Rappaport JA, Gnass E, et al
    Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.
    Hum Pathol. 2019;87:103-114.
    PubMed     Abstract available


  17. HUANG H, Chang J, Rosati S, Geurts J, et al
    Tubulopapillary adrenocortical adenoma in a patient with familial adenomatous polyposis: a morphologic, ultrastructural, and molecular study.
    Hum Pathol. 2019;87:51-56.
    PubMed     Abstract available


    April 2019
  18. HOU Y, Nitta H, Parwani AV, Li Z, et al
    PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancers.
    Hum Pathol. 2019;86:108-114.
    PubMed     Abstract available


  19. DIRSCHMID K, Sterlacci W, Woll E, Tschann P, et al
    Incidence of extramural venous invasion in colorectal carcinoma as determined at the invasive tumor front and its prognostic impact.
    Hum Pathol. 2019;86:102-107.
    PubMed     Abstract available


  20. ZHENG G, Tseng LH, Haley L, Ibrahim J, et al
    Clinical validation of coexisting driver mutations in colorectal cancers.
    Hum Pathol. 2019;86:12-20.
    PubMed     Abstract available


    March 2019
  21. LIANG WY, Wang YC, Hsu CY, Yang SH, et al
    Staging of colorectal cancers based on elastic lamina invasion.
    Hum Pathol. 2019;85:44-49.
    PubMed     Abstract available


  22. GONZALEZ I, Goyal B, Xia MD, Pai RK, et al
    DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
    Hum Pathol. 2019;85:18-26.
    PubMed     Abstract available


    February 2019
  23. MEYER SN, Galvan JA, Zahnd S, Sokol L, et al
    Co-expression of cytokeratin and vimentin in colorectal Cancer highlights a subset of tumor buds and an atypical Cancer-associated stroma.
    Hum Pathol. 2019 Feb 19. pii: S0046-8177(19)30018.
    PubMed     Abstract available


  24. PRALL F, Huhns M
    Quantitative evaluation of TP53 immunohistochemistry to predict gene mutations: lessons learnt from a series of colorectal carcinomas.
    Hum Pathol. 2019;84:246-253.
    PubMed     Abstract available


  25. LOSI L, Lancellotti C, Parenti S, Scurani L, et al
    Loss of expression of mu-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers.
    Hum Pathol. 2019;84:299-308.
    PubMed     Abstract available


    January 2019
  26. WANG Q, Dai H
    TPL2, a therapeutic potential target for cancer.
    Hum Pathol. 2019;83:224.
    PubMed    


  27. ACOSTA-GONZALEZ G, Ouseph M, Lombardo K, Lu S, et al
    Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression.
    Hum Pathol. 2019;83:115-123.
    PubMed     Abstract available


    November 2018
  28. DAWSON H, Galuppini F, Trager P, Berger MD, et al
    Validation of the international tumor budding consensus conference (ITBCC 2016) recommendations on tumor budding in stage I-IV colorectal cancer.
    Hum Pathol. 2018 Nov 11. pii: S0046-8177(18)30420.
    PubMed     Abstract available


  29. LIBERA L, Craparotta I, Sahnane N, Chiaravalli AM, et al
    Targeted gene sequencing of Lynch syndrome-related and sporadic endometrial carcinomas.
    Hum Pathol. 2018;81:235-244.
    PubMed     Abstract available


    September 2018
  30. YANG L, Chen Z, Xiong W, Ren H, et al
    High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
    Hum Pathol. 2018 Sep 17. pii: S0046-8177(18)30359.
    PubMed     Abstract available


    August 2018
  31. LIU Y, Peng K, Xie R, Zheng J, et al
    Protocadherin gamma A7 is down-regulated in colorectal cancer and associated with the prognosis in patients with wild-type KRAS.
    Hum Pathol. 2018 Aug 16. pii: S0046-8177(18)30312.
    PubMed     Abstract available


  32. CUI G, Cai F, Ding Z, Gao L, et al
    MMP14 predicts a poor prognosis in patients with colorectal cancer.
    Hum Pathol. 2018 Aug 15. pii: S0046-8177(18)30310.
    PubMed     Abstract available


  33. BIRKMAN EM, Avoranta T, Algars A, Korkeila E, et al
    EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer.
    Hum Pathol. 2018 Aug 7. pii: S0046-8177(18)30296.
    PubMed     Abstract available


    July 2018
  34. KAWAMOTO S, Kamesaki T, Ryota Masutani MT, Kitao A, et al
    Ectopic expression of band 3 anion transport protein in colorectal cancer revealed in an autoimmune hemolytic anemia patient.
    Hum Pathol. 2018 Jul 28. pii: S0046-8177(18)30288.
    PubMed     Abstract available


  35. ZHANG M, Li G, Sun X, Ni S, et al
    MET amplification, expression, and exon 14 mutations in colorectal adenocarcinoma.
    Hum Pathol. 2018;77:108-115.
    PubMed     Abstract available


  36. PYO JS, Park MJ, Kang DW
    The clinicopathological significance of micropapillary pattern in colorectal cancers.
    Hum Pathol. 2018;77:159-165.
    PubMed     Abstract available


    June 2018
  37. ZHANG Z, Ren H, Yang L, Zhang X, et al
    Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
    Hum Pathol. 2018 Jun 4. pii: S0046-8177(18)30184.
    PubMed     Abstract available


    May 2018
  38. LANG-SCHWARZ C, Melcher B, Haumaier F, Lang-Schwarz K, et al
    Budding and tumor infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
    Hum Pathol. 2018 May 19. pii: S0046-8177(18)30168.
    PubMed     Abstract available


  39. PYO JS, Park MJ, Kim CN
    TPL2 expression is correlated with distant metastasis and poor prognosis in colorectal cancer.
    Hum Pathol. 2018 May 12. pii: S0046-8177(18)30160.
    PubMed     Abstract available


    April 2018
  40. LIONTI S, Bonetti LR, Bettelli S, Spallanzani A, et al
    Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters.
    Hum Pathol. 2018 Apr 28. pii: S0046-8177(18)30148.
    PubMed     Abstract available


  41. WESTENEND PJ, Dinjens WN
    Somatic polymerase epsilon mutations as another route leading to loss of DNA MMR protein expression in endometrial carcinoma.
    Hum Pathol. 2018 Apr 7. pii: S0046-8177(18)30111.
    PubMed    


  42. HUHNS M, Krohn S, Murua Escobar H, Prall F, et al
    Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain?
    Hum Pathol. 2018;74:54-63.
    PubMed     Abstract available


    March 2018
  43. SINHA N, Gaston D, Manders D, Goudie M, et al
    Characterization of genome-wide copy number aberrations in colonic mixed adenoneuroendocrine carcinoma and neuroendocrine carcinoma reveals recurrent amplification of PTGER4 and MYC genes.
    Hum Pathol. 2018;73:16-25.
    PubMed     Abstract available


    February 2018
  44. ZHOU D, Wu Y, Jiang H, Luan J, et al
    IMP3: a potential diagnostic and therapeutic biomarker for cancers.
    Hum Pathol. 2018;72:196.
    PubMed    


  45. NONAKA D, Papaxoinis G, Lamarca A, Fulford P, et al
    A study of appendiceal crypt cell adenocarcinoma (so-called goblet cell carcinoid and its related adenocarcinoma).
    Hum Pathol. 2018;72:18-27.
    PubMed     Abstract available


    January 2018
  46. TESSITORE A, Bruera G, Mastroiaco V, Cannita K, et al
    KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease.
    Hum Pathol. 2018 Jan 30. pii: S0046-8177(18)30035.
    PubMed     Abstract available


  47. WANG L, Liu Z, Fisher KW, Ren F, et al
    Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.
    Hum Pathol. 2018;71:20-29.
    PubMed     Abstract available


    December 2017
  48. PYO JS, Son BK, Oh D, Kim EK, et al
    BRG1 is correlated with poor prognosis in colorectal cancer.
    Hum Pathol. 2017 Dec 26. pii: S0046-8177(17)30482.
    PubMed     Abstract available


  49. LE FLAHEC G, Badic B, Guibourg B, Doucet L, et al
    Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant PD-L1 expression in tumor cells.
    Hum Pathol. 2017 Dec 2. pii: S0046-8177(17)30436.
    PubMed     Abstract available


    November 2017
  50. MAMOORI A, Wahab R, Islam F, Lee K, et al
    Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
    Hum Pathol. 2017 Nov 2. pii: S0046-8177(17)30393.
    PubMed     Abstract available


    October 2017
  51. DILLON JL, Gonzalez JL, DeMars L, Bloch KJ, et al
    Universal Screening for Lynch Syndrome in Endometrial Cancers: Frequency of Germline Mutations and Identification of Patients with Lynch-Like Syndrome.
    Hum Pathol. 2017 Oct 28. pii: S0046-8177(17)30391.
    PubMed     Abstract available


  52. LEE HE, Chandan VS, Lee CT, Wu TT, et al
    Squamoid morules in the pseudoinvasive foci of colonic polyp morphologically mimic invasive carcinoma.
    Hum Pathol. 2017;68:54-60.
    PubMed     Abstract available


  53. VAN DER LINDEN M, Bult P, Nagtegaal ID, Massuger LFAG, et al
    Cervical metastases originating from a primary rectal adenocarcinoma due to a pagetoid spread.
    Hum Pathol. 2017;68:184-188.
    PubMed     Abstract available


    September 2017
  54. GURZU S, Banias L, Kovacs Z, Jung I, et al
    Epithelial-mesenchymal transition of tumor budding in colorectal cancer: the mystery of CD44-positive stromal cells.
    Hum Pathol. 2017 Sep 9. pii: S0046-8177(17)30317.
    PubMed    


  55. GIANNICO GA, Gown AM, Epstein JI, Revetta F, et al
    Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Hum Pathol. 2017;67:152-159.
    PubMed     Abstract available


    August 2017
  56. KOJIMA M, Shimazaki H, Iwaya K, Nakamura T, et al
    Intramucosal colorectal carcinoma with invasion of the lamina propria: a study by the Japanese Society for Cancer of the Colon and Rectum.
    Hum Pathol. 2017;66:230-237.
    PubMed     Abstract available


  57. COATES RF, Gardner JA, Gao Y, Cortright VM, et al
    Significance of positive and inhibitory regulators in the TGF-beta signaling pathway in colorectal cancers.
    Hum Pathol. 2017;66:34-39.
    PubMed     Abstract available


    July 2017
  58. LINO-SILVA LS, Salcedo-Hernandez RA, Espana-Ferrufino A, Ruiz-Garcia EB, et al
    Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.
    Hum Pathol. 2017;65:107-112.
    PubMed     Abstract available


  59. CAPPELLESSO R, Luchini C, Veronese N, Lo Mele M, et al
    Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis.
    Hum Pathol. 2017;65:62-70.
    PubMed     Abstract available


  60. JANG S, Hong M, Shin MK, Kim BC, et al
    KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
    Hum Pathol. 2017;65:21-30.
    PubMed     Abstract available


    June 2017
  61. MATSUSHIMA J, Yazawa T, Suzuki M, Takahashi Y, et al
    Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and beta-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
    Hum Pathol. 2017;64:179-185.
    PubMed     Abstract available


    April 2017
  62. KANADA S, Sugita A, Mikami T, Ohashi K, et al
    Microcarcinoid arising in patients with long standing ulcerative colitis: histological analysis.
    Hum Pathol. 2017 Apr 17. pii: S0046-8177(17)30107.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: